Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system

J Neurochem. 2007 Jun;101(5):1392-9. doi: 10.1111/j.1471-4159.2006.04423.x. Epub 2007 Feb 5.

Abstract

We have previously demonstrated that tissue plasminogen activator (tPA)-plasmin system participates in the rewarding effect of morphine, by regulating dopamine release in the nucleus accumbens (NAc). However, it is unclear how plasmin increases the morphine-induced release of dopamine and hyperlocomotion. In the present study we investigated whether protease activated receptor-1 (PAR-1) is involved in the regulation of acute morphine-induced dopamine release by the tPA-plasmin system. Morphine significantly but transiently increased extracellular tPA activity in the NAc, which was completely blocked by naloxone. Microinjection of a PAR-1 antagonist, (tyr(-1))-thrombin receptor activating peptide 7, into the NAc significantly reduced morphine-induced dopamine release in the NAc and hyperlocomotion although the treatment had no effect on basal dopamine release and spontaneous locomotor activity. Furthermore, the PAR-1 antagonist blocked the ameliorating effect of plasmin on the defect of morphine-induced dopamine release in the NAc of tPA-deficient mice. In contrast, intracerebroventricular injection of the PAR-1 antagonist had no effect on the antinociceptive effects of morphine in mice. These results suggest that PAR-1 is a target for the tPA-plasmin system in the regulation of acute morphine-induced dopamine release in the NAc.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Behavior, Animal
  • Dopamine / metabolism*
  • Dose-Response Relationship, Drug
  • Drug Administration Routes
  • Hyperkinesis / chemically induced
  • Hyperkinesis / metabolism*
  • In Situ Hybridization / methods
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Morphine / pharmacology
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Narcotics / pharmacology
  • Nucleus Accumbens / drug effects
  • Peptide Fragments / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, PAR-1 / antagonists & inhibitors
  • Receptor, PAR-1 / deficiency
  • Receptor, PAR-1 / physiology*
  • Time Factors
  • Tissue Plasminogen Activator / metabolism*

Substances

  • Narcotic Antagonists
  • Narcotics
  • Peptide Fragments
  • Receptor, PAR-1
  • thrombin receptor peptide SFLLRNP
  • Naloxone
  • Morphine
  • Tissue Plasminogen Activator
  • Dopamine